# FRESCO-2 (NCT04322539)

> A Study of Efficacy and Safety of Fruquintinib (HMPL-013) in Participants With Metastatic Colorectal Cancer

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT04322539
- Phase: PHASE3
- Status: COMPLETED
- Sponsor: Hutchison Medipharma Limited
- Conditions: Metastatic Colorectal Cancer; Metastatic Colon Cancer
- Interventions: Fruquintinib; Placebo
- Enrollment: 691
- Primary outcome: Overall Survival (OS)

## Commentary we found

- Podcasts: 54
- X threads: 46
- YouTube: 30
- X videos: 1

## Order

Deep, $1,950, price fixed at order: https://www.erudio.com/contact?report=fresco-2-nct04322539

## Free build

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT04322539", "email": "<work email>"}; the inbox owner confirms by the emailed link.